These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 8052621

  • 1. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein.
    Grossman SR, Johannsen E, Tong X, Yalamanchili R, Kieff E.
    Proc Natl Acad Sci U S A; 1994 Aug 02; 91(16):7568-72. PubMed ID: 8052621
    [Abstract] [Full Text] [Related]

  • 2. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa.
    Robertson ES, Grossman S, Johannsen E, Miller C, Lin J, Tomkinson B, Kieff E.
    J Virol; 1995 May 02; 69(5):3108-16. PubMed ID: 7707539
    [Abstract] [Full Text] [Related]

  • 3. Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless.
    Zimber-Strobl U, Strobl LJ, Meitinger C, Hinrichs R, Sakai T, Furukawa T, Honjo T, Bornkamm GW.
    EMBO J; 1994 Oct 17; 13(20):4973-82. PubMed ID: 7957063
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.
    Johannsen E, Koh E, Mosialos G, Tong X, Kieff E, Grossman SR.
    J Virol; 1995 Jan 17; 69(1):253-62. PubMed ID: 7983717
    [Abstract] [Full Text] [Related]

  • 5. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV.
    Yalamanchili R, Tong X, Grossman S, Johannsen E, Mosialos G, Kieff E.
    Virology; 1994 Nov 01; 204(2):634-41. PubMed ID: 7941331
    [Abstract] [Full Text] [Related]

  • 6. Transcriptional regulatory properties of Epstein-Barr virus nuclear antigen 3C are conserved in simian lymphocryptoviruses.
    Zhao B, Dalbiès-Tran R, Jiang H, Ruf IK, Sample JT, Wang F, Sample CE.
    J Virol; 2003 May 01; 77(10):5639-48. PubMed ID: 12719556
    [Abstract] [Full Text] [Related]

  • 7. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa.
    Henkel T, Ling PD, Hayward SD, Peterson MG.
    Science; 1994 Jul 01; 265(5168):92-5. PubMed ID: 8016657
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein.
    Ling PD, Rawlins DR, Hayward SD.
    Proc Natl Acad Sci U S A; 1993 Oct 15; 90(20):9237-41. PubMed ID: 8415684
    [Abstract] [Full Text] [Related]

  • 13. The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains.
    Tong X, Yalamanchili R, Harada S, Kieff E.
    J Virol; 1994 Oct 15; 68(10):6188-97. PubMed ID: 8083959
    [Abstract] [Full Text] [Related]

  • 14. The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements.
    Waltzer L, Logeat F, Brou C, Israel A, Sergeant A, Manet E.
    EMBO J; 1994 Dec 01; 13(23):5633-8. PubMed ID: 7988560
    [Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA.
    Waltzer L, Perricaudet M, Sergeant A, Manet E.
    J Virol; 1996 Sep 01; 70(9):5909-15. PubMed ID: 8709211
    [Abstract] [Full Text] [Related]

  • 16. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines.
    Sauder C, Haiss P, Grässer FA, Zimber-Strobl U, Mueller-Lantzsch N.
    J Gen Virol; 1994 Nov 01; 75 ( Pt 11)():3067-79. PubMed ID: 7964616
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The domain of Epstein-Barr virus nuclear antigen 1 essential for binding to oriP region has a sequence fitted for the hypothetical basic-helix-loop-helix structure.
    Inoue N, Harada S, Honma T, Kitamura T, Yanagi K.
    Virology; 1991 May 01; 182(1):84-93. PubMed ID: 1850915
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.